Tailoring Tryptophan Synthase TrpB for Selective Quaternary Carbon Bond Formation by Dick, Markus et al.
1 
 
Tailoring Tryptophan Synthase TrpB for Selective Quaternary 
Carbon Bond Formation 
 
 
Markus Dick,1 Nicholas S. Sarai,1 Michael W. Martynowycz,2 Tamir 
Gonen,2 and Frances H. Arnold1,* 
 
 
1Division of Chemistry and Chemical Engineering 210-41,  
California Institute of Technology, 1200 East California Boulevard,  
Pasadena, California 91125, United States 
 
2Howard Hughes Medical Institute, David Geffen School of Medicine, Departments 
of Biological Chemistry and Physiology, University of California, Los Angeles, Los 
Angeles, California 90095, United States 
 
 
 
 
 
Supporting Information  
2 
 
Contents 
 
1 Activity of TrpB towards N-alkylation product of 3-methyloxindole 1 ............................................ 3 
2 N- and C-alkylation products ......................................................................................................... 3 
3 NMR of 3-methyloxindole in chloroform and water ....................................................................... 4 
4 First round of random mutagenesis ............................................................................................... 5 
5 Cooperative effect of W172R and S185T on activity of Pf0A9 E104G .............................................. 5 
6 Active-site residues targeted in site-saturation mutagenesis libraries ............................................ 6 
7 List of substrates not accepted by Pfquat for C–C bond formation .................................................... 6 
8 Procedures for protein expression and characterization ................................................................ 6 
8.1 Cloning, expression, and purification of TrpB variants ................................................................................. 6 
8.2 Construction of site-saturation mutagenesis libraries .................................................................................. 7 
8.3 Construction of random mutagenesis libraries ............................................................................................ 7 
8.4 Library expression and screening ................................................................................................................. 7 
8.5 Small- and large-scale reactions with TrpB ................................................................................................... 8 
8.6 Separation of diastereomers ........................................................................................................................ 8 
8.7 Determination of optical purity .................................................................................................................... 8 
8.8 Calibration curve for measuring HPLC yields ................................................................................................ 9 
9 Microcrystal electron diffraction (MicroED) ................................................................................... 9 
9.1 Sample preparation ...................................................................................................................................... 9 
9.2 Data collection .............................................................................................................................................. 9 
9.3 Structural data and statistics ...................................................................................................................... 10 
10 Synthesis and characterization of oxindole derivatives and related substrates ............................ 11 
10.1 General information ................................................................................................................................... 11 
10.2 Synthesis of starting material for biocatalytic reactions ............................................................................. 11 
10.2.1 Methylation of 3-methyl-2-oxindole ............................................................................................ 11 
10.2.2 Alkylation of 2-oxindole at C3 ....................................................................................................... 11 
10.2.3 Synthesis of the lactone ................................................................................................................ 13 
10.2.4 Synthesis of 3-hydroxyl oxindole .................................................................................................. 13 
10.2.5 Synthesis of 1-methyl-2,3-dihydro-1H-inden-2-one ..................................................................... 13 
10.3 Analytics of TrpB catalyzed product ........................................................................................................... 14 
11 DNA and Protein sequences ........................................................................................................ 16 
12 References .................................................................................................................................. 17 
 
  
3 
 
1 Activity of TrpB towards N-alkylation product of 3-methyloxindole 1 
 
 
Figure S1: HPLC chromatogram for the TrpB catalyzed reaction of 3-methyloxindole 1 and serine 2. In this specific 
case, TmTrpB9D8*-E103S1 (20 µM) was used with 20 mM 3-methyloxindole 1 and 1 eq. serine 2 at 55 °C overnight, 
giving roughly 28% HPLC yield. A 2 min gradient from 5-50% acetonitrile in water (including 0.1 acetic acid) was used 
for reverse phase HPLC. The connectivity of the product was confirmed by NMR of the isolated product.  
 
2 N- and C-alkylation products 
 
 
Figure S2: LC-MS chromatogram of the Pf0A9 E104G catalyzed reaction of 3-methyloxindole 1 and serine 2. The 
chromatogram only shows signals for compounds with a mass of 235 g/mol, which corresponds to the protonated 
products shown. For the reaction, 20 mM of 3-methyloxindole 1, 1 eq. of serine 2 and 25% v/v clear cell lysate 
(corresponding to roughly 25 µM final concentration of Pf0A9 E104G2) were used. For separation, a 3 min gradient 
from 5-95% acetonitrile on reverse-phase LC-MS was used. The product yield (both N- and C-alkylation) was less than 
0.1%. An authentic standard was used to assign the retention times to the corresponding products. 
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3 NMR of 3-methyloxindole in chloroform and water 
 
 
Figure S3: Comparison of NMR spectra of a) 3-methyloxindole and b) nitromethylbenzene in chloroform (green) 
and standard reaction conditions for TrpB (50 mM potassium phosphate buffer (KPi), pH 9) (red). Water 
suppression was used for the NMR spectra in aqueous solution. In the case of the oxindole, both NMR spectra are 
very similar and show only the keto-form of oxindole. For the nitroalkane, an equilibrium of around 1:1 could be 
detected between the keto- and enolate-forms. 
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4 First round of random mutagenesis 
 
  
Figure S4: Global, random mutagenesis of Pf0A9 E104G using two different MnCl2 concentrations for introducing 
random mutations. For screening, 20 mM of 1,3-dimethyloxindole 4, 1 eq. serine 2 and 50 µL clarified cell lysate (see 
8.4) were used. Product formation was measured by LC-MS (see 8.4). Because the parental activity for the substrate 
was very low, automatic peak integration failed for certain parent enzymes.  
  
5 Cooperative effect of W172R and S185T on activity of Pf0A9 E104G  
 
 
Figure S5: Influence of W172R and S185T and their combination on activity of Pf0A9 E104G (parent) for 1,3-
dimethyloxindole alkylation activity.  
*These variants carry an additional mutation (Q217R), which was randomly inserted in the first round of directed 
evolution. Because an activity assay showed that this mutation had no influence on either the parental activity or on 
the activity of W172R-S185T, this mutation was not removed and was kept as a neutral mutation for further rounds 
of directed evolution. 
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6 Active-site residues targeted in site-saturation mutagenesis libraries 
 
 
Figure S6: a) Active site of Pf(β-Me) with the PLP-bound amino-acrylate (PDB ID: 5vm5). All six residues were 
targeted for site-saturation libraries (see 8.2). b) Best hits of six site-saturation libraries. Shown is the relative activity 
compared to parent (Pf0A9 E104G after two rounds, containing additional mutations W172R-S185T and R170C-
V221A). 
 
7 List of substrates not accepted by Pfquat for C–C bond formation 
 
 
Figure S7: No C–C bond formation was detected when 20 mM of these nucleophiles and 1 eq. serine were 
incubated with 40 µM Pfquat. Hypothetical products are drawn in grey. For substrate 21, a product with the correct 
mass was detected. However, this was the N-alkylation product.  
 
8  Procedures for protein expression and characterization 
8.1 Cloning, expression, and purification of TrpB variants 
The genes encoding Pf0A9 E104G and TmTrpB 9D8star E103S (UNIPROT ID P50909 for wt TrpBs) were previously 
cloned into pET-22b(+) with a C-terminal His-tag. Protein expression of the variants was carried out in Escherichia coli 
BL21 E. cloni Express cells (Lucigen) by inoculating 5 mL of Lysogeny Broth containing 100 μg/mL carbenicillin (LBcarb) 
with a single colony and incubating the pre-culture overnight at 37 °C and 220 rpm. This overnight culture was used 
to inoculate 900 mL of Terrific Broth containing 100 μg/mL carbenicillin (TBcarb). The expression cultures were shaken 
at 37 °C and 220 rpm for ~2 h, at which point the OD600 was 0.5–0.7. The cultures were then cooled on ice for around 
30 min and induced with by the addition of isopropyl β-D-thiogalactopyranoside (IPTG, final concentration of 1 mM). 
The culture was shaken at 220 rpm and 22 °C for another 20 h and then harvested by centrifugation at 5,000 × g for 
5 min. The cell pellets were stored at –20 °C until further use. 
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Cells were resuspended in 5 volumes of potassium phosphate buffer (KPi, 50 mM, pH 8) containing 0.2 mM PLP, 
disrupted via sonication, and after centrifugation (15 min at 5,000 × g) the supernatant was either directly used for 
reaction as cell lysate or subjected to purification. For protein purification, the lysate was loaded onto a NiNTA-
column. After washing with KPi-buffer containing 30 mM imidazole the enzyme was eluted with 250 mM imidazole. 
PD-10 desalting columns were used to buffer exchange the solution to 50 mM KPi. The protein concentration was 
determined via the Bradford assay (Bio-Rad). 
8.2 Construction of site-saturation mutagenesis libraries 
PCR was done using Phusion polymerase (New England Biolabs) according to the standard protocol. For the 
construction of site-saturation libraries, the 22-codon trick first described by Kille et al. was used.3 Three primers 
were designed containing codons NDT (encoding Ile, Asn, Ser, Gly, Asp, Val, Arg, His, Leu, Phe, Tyr, and Cys), VHG 
(encoding Met, Thr, Lys, Glu, Ala, Val, Gln, Pro, and Leu), and TGG (encoding Trp). These three primers were mixed 
12:9:1. Then, the mutations were introduced with QuikChange PCR using a plasmid that contained the parent gene 
in the pET-22b(+) vector as template. The linear plasmid was digested with DpnI, purified with a preparative agarose 
gel, cyclized via the Gibson method, purified again, and transformed into BL21 E. cloni Express cells using 
electroporation. 
8.3 Construction of random mutagenesis libraries 
Random mutations were inserted into the TrpB gene with error-prone PCR using Taq polymerase (New England 
Biolabs) according to the following scheme.  
 added volume [µL]  Thermocycler program  
Taq buffer (10×) 10  95 °C 40 s  
dNTP mix (200 μM) 2  95 °C 30 s 
30x forward primer (10 μM)a 2  55 °C 30 s 
reverse primer (10 μM)b 2  68 °C 80 s 
template DNA (50 ng/µl) 1  68 °C 5 min  
MnCl2 (1 mM) 20/30      
Taq DNA Polymerase 0.5     
Water add to 100      
aGAAATAATTTTGTTTAACTTTAAG, corresponding to the NdeI restriction site of the pET-22b(+) vector.  
bGCCGGATCTCAGTGGTGGTGGT, corresponding to the XhoI restriction site of the pET-22b(+) vector. 
 
The PCR product was purified using a preparative agarose gel, and the gene was cloned into an empty pET-22b(+) 
vector between restriction sites NdeI and XhoI using the Gibson method, purified again and transformed into BL21 
E. cloni Express cells using electroporation. Libraries with 200 and 300 µM MnCl2 were screened to validate which 
library gave the optimal balance of inactivation rate and diversity.  
8.4 Library expression and screening 
BL21 E. cloni Express cells carrying the gene for TrpB variants were grown overnight in 96-well deep-well plates 
(300 µL/well LBcarb) at 37 °C, 250 rpm according to the following scheme.  
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A P            
B  P           
C   P          
D    P         
E     P        
F      P       
G       B      
H        B     
P = parent enzyme; B = blank (sterile control) 
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1 mL of TBcarb medium in each well of a new 96-well plate was inoculated with 20 µL of the overnight cultures, 
incubated for 2 h at 200 rpm, 37 °C and then chilled on ice for 30 min. Gene expression was induced by the addition 
of IPTG (1 mM final concentration). The cultures were shaken at 250 rpm and 22 °C. After 20 h, the cultures were 
centrifuged at 5,000 × g for 10 min and frozen at –20 °C. For screening, cells were thawed and lysed by the addition 
of 300 µL/well of KPi (50 mM, pH 8.0), with 1 mg/mL lysozyme, 0.1 mg/mL DNase I, 200 µM PLP, and 2 mM MgCl2. 
The plates were incubated for 30 min at 37 °C, then transferred to a water bath equilibrated to 75 °C. After 30 min, 
the plates were chilled in ice, subjected to centrifugation at 5,000 × g and 4 °C for 10 min. 20-50 µL of the clear lysate 
was added to a reaction mixture containing 20 mM serine (0.4 M stock solution in water) and 20 mM 3-
methyloxindole (0.4 M stock solution in DMSO) in 50 mM KPi buffer (pH 9) such that the total volume of the wells in 
the 96-well plate was 200 µL. The plates were incubated for 14 h at 55 °C, chilled on ice and 800 µL of acetonitrile / 
1 M HCl (ratio 1:1) was added. The plates were subjected to centrifugation (5,000 × g, 5 min) and 200 µL of the 
supernatant was transferred to an assay plate. Each well was analyzed with a C-18 silica column (4.6 × 50 mm) using 
acetonitrile/water (0.1% acetic acid by volume): 5% to 70% acetonitrile over 1 min, 70% for 0.5 min; 1.5 mL/min. For 
validation, a gradient of 5% to 95% acetonitrile over 2 min followed by 0.5 min at 95% was used.  
8.5 Small- and large-scale reactions with TrpB 
Small-scale reactions to measure the activity of variants in terms of total turnover numbers (TTN) and to evaluate 
the substrate scope were performed in a similar way to the plate screening reactions (see 8.4). For these reactions, 
20-50 µM of purified enzyme and 50-100 mM substrate were used in 200 µL total volume (the exact concentrations 
are shown in Figure 4 and 5). The reaction to product 12 was run under anaerobic conditions because the substrate 
can easily oxidize. For NMR and high-resolution mass spectrometry, 50 mM of the nucleophile, 2 eq. of serine and 
0.2 mol% of purified enzyme were used and the total volume was increased to 30 mL. A preparative-scale reaction 
using 1 mmol nucleophile (50 mM concentration) and cell lysate from 100 mL expression culture (resuspended in 
5 mL of 50 mM KPi buffer, pH 9) was run for 3-methyloxindole 1 with Pfquat. In order to increase the overall yield, 
5 eq. of serine were added while the reaction time was extended to 24 h.  
All reactions were performed overnight at 55 °C in either plastic Eppendorf tubes, glass vials, or in 100 mL flasks. 
For non-preparative scale reactions, the work-up is described in 8.4. Preparative-scale reactions were frozen, 
lyophilized and the residual solid was washed twice with toluene to remove residual DMSO. The solid was then 
dissolved in 2-5 mL of 1 M HCl. The product was then subjected to purification by preparative reverse-phase 
chromatography performed on a Biotage Isolera One purification system; C-18 silica was used as the stationary 
phase, with methanol as the strong solvent and water as the weak solvent. The product was eluted with a gradient 
from 1% to 100% methanol over 10 CV. The fractions containing product were combined and methanol was removed 
in vacuo. Then the fractions were frozen and lyophilized to remove water. The products were obtained as the 
hydrochloride salts. 
8.6 Separation of diastereomers 
For separation of the major diastereomers of the 3-methyloxindole product 3b for analysis via micro-crystal electron 
diffraction (Section 9), 1-5 mg of the lyophilized substance (see 8.5) was dissolved in 100 µL of water. 20 µL of the 
solution was loaded on an Eclipse XDB-C8, 4.6 x 150mm column. A 4.5 min isocratic method with a ratio of 9:1 (water 
: acetonitrile) including 0.1% acetic acid with a flowrate of 1 mL/min on a reverse-phase HPLC was used. The major 
diastereomer eluted at 3.48 min and the minor at 3.83 min. 
8.7 Determination of optical purity 
FDNP-alaninamide was used as a solution in acetone (33 mM). In a 2-mL vial, the amino acid (0.50 μmol) was 
dissolved in 1 M aq. NaHCO3 (100 μL). FDNP- alaninamide (10 μL, 0.33 μmol) was added, then the vial was placed in 
an incubator at 37 °C and shaken at 230 rpm. After 4 h, the reaction mixture was allowed to cool to room 
temperature, then diluted with 1:1 CH3CN/H2O (500 μL). The resulting solution was analyzed directly by LCMS with a 
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20-30 min isocratic method of 20% acetonitrile plus 0.1% acetic acid in H2O. The total ion count filtered for the 
expected mass was used to identify LC peaks for the derivatization products. Each amino acid was derivatized with 
both racemic and enantiopure FDNP-alaninamide for comparison. Since the diastereomers for most of the products 
were not separated, both diastereomers were analyzed simultaneously. As such, four independent peaks could be 
observed for the control sample derivatized with racemic FDNP-alaninamide while two were observed for the 
product derivatized with enantiopure FDNP-alaninamide. This procedure was adapted from Marfey et al.4 
8.8 Calibration curve for measuring HPLC yields  
To determine the HPLC yield of the C-alkylation product 3b of 3-methyloxindole 1 and serine 2, different 
concentrations of the isolated product (see 8.5) in acetonitrile/1 M HCl (1:1) were prepared and analyzed by HPLC 
using the 2.5 min method described in 8.4. For comparison, the same calibration curve was measured for substrate 
1. The ratio of 1 divided by 3b was 0.91, which was used calculate product formation based on an authentic standard 
with a defined substrate concentration.  
 
 
 
9 Microcrystal electron diffraction (MicroED)  
9.1 Sample preparation 
MicroED sample preparation was conducted as described.5-6 Briefly, samples were received as lyophilized powders 
taken directly after purification without crystallization attempts. Oxindole 3b was found to quickly change from a dry 
powder to a hard, resin-like material, whereas ketone 14 remained a dry powder while stored. Pre-clipped Quantifoil 
R2/2 Cu300 grids were dropped directly into the vials of purified ketone 14 and mechanically agitated for 15 s. The 
oxindole 3b resin-like material was dissolved in 20 µL of ethanol; 1 µL of this was applied to the carbon side of the 
pre-clipped EM grid and allowed to dry under vacuum for 15 min. The grids were then plunged into liquid nitrogen, 
and cryo-transferred into the transmission electron microscope for investigation.  
9.2 Data collection 
Data were collected on a Thermo-Fisher Talos Arctica transmission electron microscope operating at an acceleration 
voltage of 200kV and cooled to liquid nitrogen temperatures as described.7 Crystals were identified by low-
magnification imaging. MicroED data collection was conducted on select crystals as previously described.7-8 Crystals 
were continuously rotated in a parallel electron beam while MicroED data were collected by a bottom-mount Thermo 
Fisher CetaD CMOS 4k x 4k detector operating in rolling shutter mode. Images were binned by 2. Typical data 
collection was performed using a continuous rotation rate of 0.5°/s with frames being read out every 1 s over an 
angular wedge ~60°. The exposure rate was calibrated to 0.01e-Å-2s-1. Individual crystals were isolated using a select 
area aperture to reduce noise.  
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Movies were initially saved as MRC files and converted to SMV format using the MicroED tools software developed 
in-house and freely available at: https://cryoem.ucla.edu/pages/MicroED.9 
MicroED data were indexed and integrated in XDS.10 Integrated datasets were merged and scaled in XSCALE.10 The 
structures were solved by ab initio direct methods in SHELXT,11 and refined in SHELXL.12 
9.3 Structural data and statistics 
Individual integration and refinement statistics for these two structures can be found below with their corresponding 
densities. 
 
 
Oxindole (3b) 
Temperature [K] 80 
Space group P 21/c  
Unit cell (a,b,c) [Å] 
(⍺,β,ɣ) (°) 12.15, 8.98, 10.28 90, 99.41, 90 
Reflections [#] 2524 
Robserved 10.1 
CC1/2 98.8 
Resolution range [Å] 7.19 – 0.9 
Completeness [%] 65.1 
Exposure [e-Å-2s-1] <1 
R / wR2 / GooF 20 / 41.9 / 2.3 
 
 
Ketone (14) 
Temperature [K] 80 
Space group P 212121 
Unit cell (a,b,c) [Å] 
(⍺,β,ɣ) (°) 6.66, 9.10, 20.26 90, 90, 90 
Reflections [#] 3055 
Robserved 19.6 
CC1/2 99.4 
Resolution range [Å] 6.76 – 0.9 
Completeness [%] 83.0 
Exposure [e-Å-2s-1] <1 
R / wR2 / GooF 28.5 / 53.9 / 1.59 
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10 Synthesis and characterization of oxindole derivatives and related substrates 
10.1 General information 
Carbon and proton NMR spectra were recorded on a Bruker 400 MHz (100 MHz) spectrometer equipped with a 
cryogenic probe. Proton chemical shifts are reported in ppm (δ) relative to tetramethylsilane and calibrated using 
the solvent resonance of CDCl3 (δ 7.18 ppm), methanol-d4 (δ 3.31 ppm), or D2O (δ 4.79 ppm). Data are reported as 
follows: chemical shift (multiplicity [singlet (s), doublet (d), doublet of doublets (dd), doublet of doublets of doublets 
(ddd), triplet (t), triplet of doublets (td), multiplet (m)], coupling constants [Hz], integration). Carbon NMR spectra 
were recorded with complete proton decoupling. Carbon chemical shifts are reported in ppm relative to 
tetramethylsilane and calibrated using the residual solvent proton resonance as an absolute reference. All NMR 
spectra were recorded at around 25 °C.  
Normal phase purification was performed on a Biotage Isolera One purification system, using silica as the 
stationary phase, with ethyl acetate as the strong solvent and hexane as the weak solvent.  
High-resolution mass spectrometry (HRMS) data were acquired using an Agilent 6200 TOF equipped with 
electrospray ionization (ESI). 
10.2 Synthesis of starting material for biocatalytic reactions 
10.2.1 Methylation of 3-methyl-2-oxindole 
 
 
 
Methylation of oxindoles at the nitrogen was performed according to Liegault et al. with small adaptations.13 4 mmol 
3-methyl-2-oxindole 1 was dissolved in 100 mL anhydrous toluene, 1.05 eq. of NaH were added and the reaction 
mixture was stirred for 20 min at 60 °C. 1.2 eq. of dimethyl sulfate were added dropwise. After 2 h at 60 °C and 1 h 
at 90 °C, the reaction mixture was cooled to room temperature and quenched with 100 mL brine. The organic layer 
was extracted using 2 x 40 mL EtOAc, dried with MgSO4, concentrated under reduced pressure, and purified by silica 
gel chromatography (gradient: hexane : ethyl acetate 10:1 à 2:1) to afford 4 with 64% yield. 
1H NMR (300 MHz, chloroform-d) δ 7.40 – 7.16 (m, 2H), 7.05 (td, J = 7.5, 1.1 Hz, 1H), 6.82 (ddt, J = 7.8, 1.0, 0.5 Hz, 
1H), 3.20 (s, 2H), 1.47 (d, J = 7.6 Hz, 3H). 
 
10.2.2 Alkylation of 2-oxindole at C3 
 
 
 
A solution of oxindole (3 mmol) in dry THF (4 mL) under argon was cooled to -25 °C using dry ice in acetone and 
treated drop wise with n-butyl lithium (2 eq.). To the resulting solution was added 2 eq. of N,N,N',N'-
tetramethylethylenediamine (TMEDA). After 30 min., 6 mmol of iodoalkane were added and the reaction mixture 
was allowed to warm to room temperature and stirred overnight. The reaction mixture was poured into aqueous 
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NH4Cl solution and extracted with EtOAc (2x), the combined organic layers were washed with dil. HCl, water, brine, 
dried (MgSO4) and concentrated under reduced pressure. The crude extract was purified by silica gel chromatography 
(gradient: hexane : ethyl acetate 10:1 à 2:1) to afford the desired product with 50-70% yield (the desired C-alkylation 
product eluted later than the less polar N-alkylation site product (around 20-30%).  
 
 
 
1H NMR (400 MHz, chloroform-d) δ 7.47 (s, 1H), 7.20 – 7.10 (m, 2H), 6.97 (td, J = 7.5, 1.0 Hz, 1H), 6.79 (ddt, J = 7.7, 
1.1, 0.6 Hz, 1H), 3.38 (t, J = 5.7 Hz, 1H), 2.04 – 1.89 (m, 2H), 0.85 (t, J = 7.4 Hz, 3H). 
 
 
 
1H NMR (400 MHz, chloroform-d) δ 7.66 (s, 1H), 7.20 – 7.09 (m, 2H), 6.97 (td, J = 7.5, 1.0 Hz, 1H), 6.80 (ddt, J = 7.7, 
1.1, 0.6 Hz, 1H), 3.4 (t, J = 5.7 Hz, 1H), 2.04 – 1.89 (m, 2H), 0.85 (t, J = 7.4 Hz, 3H). 
 
 
1H NMR (400 MHz, chloroform-d) δ 7.18 – 7.10 (m, 2H), 6.96 (td, J = 7.6, 1.1 Hz, 1H), 6.80 (ddd, J = 7.7, 1.1, 0.6 Hz, 
1H), 3.43 (t, J = 5.7 Hz, 1H), 2.00 – 1.73 (m, 2H), 1.40 – 1.17 (m, 4H), 0.81 (t, J = 6.9 Hz, 3H). 
 
 
 
1H NMR (400 MHz, chloroform-d) δ 7.81 (s, 1H), 6.90 (dddt, J = 8.0, 2.5, 1.2, 0.5 Hz, 1H), 6.85 (dddd, J = 9.3, 8.4, 2.6, 
0.8 Hz, 1H), 6.73 (dd, J = 8.5, 4.3 Hz, 1H), 3.45 – 3.35 (m, 1H), 1.43 (d, J = 7.7 Hz, 3H). 
 
 
1H NMR (400 MHz, chloroform-d) δ 7.59 (s, 1H), 7.06 (ddt, J = 8.0, 1.1, 0.5 Hz, 1H), 6.95 (dd, J = 7.9, 1.9 Hz, 1H), 6.82 
(d, J = 1.8 Hz, 1H), 3.36 (qd, J = 7.6, 1.1 Hz, 1H), 1.41 (d, J = 7.7 Hz, 3H). 
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10.2.3 Synthesis of the lactone 
 
 
Synthesis of the lactone was performed according to Wang et al. with small adaptations.14 In a dry 50 mL two-necked 
flask, to a solution of phenol (10 mmol) in DCM (20 mL) at 25 °C was added 12 mmol TiCl4 dropwise. The reaction 
mixture was cooled to 0 °C and methyl pyruvate (12 mmol) slowly added, then stirred at 25 °C for 2 h. AcOH (6 mL) 
and Zn (10 mmol) was then added slowly and the reaction mixture was heated at reflux for 3 h, filtered and 
concentrated under vacuum. To the residue was added 10% HCl (6 mL) and Et2O (6 mL); the mixture was stirred at 
25 °C for 3 h. After the reaction was completed, it was extracted with EtOAc (10 mL × 3) and the combined organic 
phases were dried over Na2SO4. The residue was concentrated under reduced pressure and purified by column 
chromatography (gradient: hexane : ethyl acetate 10:1 à 1:2) to afford the desired product with 30% yield. 
1H NMR (400 MHz, Chloroform-d) δ 7.27 – 7.18 (m, 1H), 7.22 – 7.15 (m, 1H), 7.13 – 7.00 (m, 2H), 3.66 (q, 7.6 Hz, 1H), 
1.51 (d, J = 7.6 Hz, 3H). 
 
10.2.4 Synthesis of 3-hydroxyl oxindole 
 
 
 
 
Sodium borohydride (7.5 mmol, 1.5 eq.) was added in small portions to a stirred suspension of isatin (5 mmol) in 
30 mL of a 1:1 dichloromethane/ethanol mixture at 0 °C. The mixture was stirred at 0 °C until the suspension became 
colorless (about 5 min). Then water (5 mL) was added and the reaction mixture was stirred until bubbling stopped. 
The mixture was extracted with dichloromethane (3 x 20 mL). The combined organic extracts were dried (MgSO4) 
and the solvent evaporated under reduced pressure (yield: 85%). The procedure was performed according to Wu et 
al.15 
1H NMR (400 MHz, deuterium oxide) δ 7.44 (ddq, J = 7.4, 1.2, 0.6 Hz, 1H), 7.35 (dddd, J = 8.4, 7.7, 1.7, 1.0 Hz, 1H), 
7.15 (tt, J = 7.7, 0.7 Hz, 1H), 6.99 (dq, J = 7.8, 0.5 Hz, 1H), 5.11 (s, 1H). 
 
10.2.5 Synthesis of 1-methyl-2,3-dihydro-1H-inden-2-one 
Methylation of the ketone at the 1-position was performed according to Koppes et al.16  
Step 1: Synthesis of 1-(1H-inden-2-yl)pyrrolidine 
 
 
A mixture of 2-indanone (3.0 g, 22.65 mmol, 1 eq.) and pyrrolidine (2.4 mL, 29.45 mmol, 1.3 eq.) in anhydrous 
toluene was refluxed under nitrogen with azeotropic removal of water for 3 h. The mixture was then cooled to room 
temperature and concentrated to dryness in vacuo. 
Step 2: Synthesis of 1-methyl-2,3-dihydro-1H-inden-2-one 
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4 g of 1-(1H-inden-2-yl)pyrrolidine (1 eq., 22 mmol) was dissolved in 50 mL of dioxane and 41 mL (66 mmol, 3 eq.) 
methyl iodide was added. After 12 h of reflux, 10 mL of water and 0.4 mL of acetic acid was added to the reaction 
mixture. After a further 4 h of reflux, the solution was quenched by pouring it into a saturated NaHCO3 solution and 
the resulting mixture was extracted with ether. The combined ether extracts were washed with water and brine, 
dried over MgSO4, and concentrated to dryness in vacuo. The crude product was purified by column chromatography 
(gradient: hexane : ethyl acetate 10:1 à 1:2) to afford the desired product with 10% yield. 
1H NMR (400 MHz, chloroform-d) δ 7.29 – 7.15 (m, 4H), 3.55 – 3.37 (m, 3H), 1.35 (d, J = 7.5 Hz, 3H). 
10.3 Analytics of TrpB catalyzed product 
 
Compound 3b (HCl salt). The product was obtained as a 5:1 mixture of two diastereomers, 
which were separated using preparative HPLC (see 8.6) to determine the relative configuration 
using MicroED (see section 9). 
Major diastereomer (S, S) – (α, γ): 1H NMR (400 MHz, deuterium oxide) δ 7.38 – 7.29 (m, 2H), 
7.15 (t, J = 7.8 Hz, 1H), 7.05 (d, J = 7.6 Hz, 1H), 3.62 (dd, J = 8.8, 3.8 Hz, 1H), 2.68 (dd, J = 14.6, 
8.8 Hz, 1H), 2.41 (dd, J = 14.6, 4.9 Hz, 1H), 1.42 (s, 3H). 13C NMR (101 MHz, deuterium oxide) δ 
183.3, 171.0, 140.4, 132.0, 128.9, 123.4, 123.2, 110.8, 50.6, 47.3, 36.5, 24.8. 
Minor Diastereomer (S, R) – (α, γ): 1H NMR (400 MHz, deuterium oxide) δ 7.43 – 7.29 (m, 2H), 7.20 (td, J = 7.5, 1.0 
Hz, 1H), 7.09 (d, J = 7.7 Hz, 1H), 3.73 (dd, J = 7.5, 6.4 Hz, 1H), 2.61 (dd, J = 15.0, 7.5 Hz, 1H), 2.34 (dd, J = 15.0, 6.5 Hz, 
1H), 1.45 (s, 3H). 13C NMR (101 MHz, deuterium oxide) δ 183.9, 171.1, 140.2, 132.4, 128.9, 123.3, 123.0, 111.0, 50.4, 
47.3, 35.8, 24.7. 
HRMS (ESI) (m/z) for [M+H]+ (C12H14ClN2O3) calculated 235.1077, observed 235.108.  
Enantiopurity (both diastereomers): >99%. 
 
Compound 5 (HCl salt). The product was obtained as a 5:1 mixture of two diastereomers. 
Due to signal overlap, all NMR signals could only be assigned for the major diastereomer.  
Major diastereomer (S, S) – (α, γ): 1H NMR 1H NMR (400 MHz, deuterium oxideδ 7.26 (d, J = 
8.0 Hz, 1H), 7.13 (d, J = 8.1 Hz, 1H), 7.08 (s, 1H), 3.59 (dd, J = 9.2, 4.3 Hz, 1H), 2.63 (dd, J = 
14.6, 9.2 Hz, 1H), 2.39 (dd, J = 14.5, 4.8 Hz, 1H), 1.41 (s, 3H). 13C NMR (101 MHz, deuterium 
oxide) δ 183.31, 171.15, 141.7, 133.7, 130.6, 124.5, 122.9, 111.1, 50.7, 47.1, 36.5, 24.8. 
HRMS (ESI) (m/z) for [M+H]+ (C12H15N2O3) calculated 269.0687, observed 269.0689.  
Enantiopurity (both diastereomers): >99%. 
 
Compound 6 (HCl salt). The product was obtained as a 7:2 mixture of two diastereomers. 
Due to signal overlap, all NMR signals could only be assigned for the major diastereomer.  
Major diastereomer (S, S) – (α, γ): 1H NMR (400 MHz, Deuterium Oxide) δ 7.04 (dd, J = 8.4, 
2.6 Hz, 1H), 6.98 – 6.93 (m, 1H), 6.89 (dd, J = 8.6, 4.4 Hz, 1H), 3.55 (dd, J = 9.2, 4.7 Hz, 1H), 
2.54 (dd, J = 15.2, 9.3 Hz, 1H), 2.31 (dd, J = 14.9, 4.8 Hz, 1H), 1.32 (s, 3H). 
13C NMR (101 MHz, Deuterium Oxide) δ 183.31, 170.9, 160.4, 158.6, 136.4, 133.7, 133.6, 
115.3, 50.4, 47.9, 36.5, 24.8. 
HRMS (ESI) (m/z) for [M+H]+ (C12H14FN2O3) calculated 253.0983, observed 253.0984.  
Enantiopurity (both diastereomers): >99%. 
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Compound 9 (HCl salt). The product was obtained as a 2:1 mixture of two diastereomers. Due 
to signal overlap, all NMR signals could only be assigned for the major diastereomer.  
Major diastereomer (S, S) – (α, γ): 1H NMR (400 MHz, deuterium oxide) δ 7.37 – 7.29 (m, 2H), 
7.17 (td, J = 7.6, 1.0 Hz, 1H), 7.05 (dd, J = 7.9, 0.9 Hz, 1H), 3.57 (dd, J = 8.6, 5.0 Hz, 1H), 2.68 (dd, 
J = 14.5, 8.5 Hz, 1H), 2.38 (dd, J = 14.6, 5.5 Hz, 1H), 2.03 – 1.78 (m, 2H), 0.55 (t, J = 7.5 Hz, 3H). 
13C NMR (101 MHz, deuterium oxide) δ 182.76, 171.42, 141.39, 129.97, 128.92, 123.83, 123.19, 110.55, 50.85, 38.68, 
36.55, 31.94, 6.97. 
HRMS (ESI) (m/z) for [M+H]+ (C13H17N2O3) calculated 249.1234, observed 249.124.  
Enantiopurity >99%. Due to signal overlap after derivatization and LCMS separation (see 8.7), an ee>99% could only 
be confirmed for one diastereomer. 
 
 
Compound 13 (HCl salt). The product was obtained as a 5:4 mixture of two diastereomers.  
Major diastereomer (S, S) – (α, γ): 1H NMR (400 MHz, deuterium oxide) δ 7.48 – 7.41 (m, 2H), 
7.20 (td, J = 7.6, 1.0 Hz, 1H), (dd, J = 7.9, 0.8 Hz, 1H), 3.58 (dd, J = 10.2, 5.4 Hz, 1H), 3.27 (s, 3H), 
2.65 (dd, J = 15.4, 8.8 Hz, 1H), 2.44 (dd, J = 14.5, 4.9 Hz, 1H), 1.41 (s, 3H). 
13C NMR (101 MHz, deuterium oxide) δ 181.23, 171.19, 142.75, , 131.49, 128.97, 123.60, 
122.97, 109.60, 50.81, 46.96, 36.60, 26.29, 24.86. 
Minor diastereomer (S, R) – (α, γ): 1H NMR (400 MHz, deuterium oxide) δ 7.42 – 7.35 (m, 2H), 7.26 (td, J = 7.6, 1.0 
Hz, 1H), 7.17 (dd, J = 7.8, 1.3 Hz, 1H), 3.57 (dd, J = 11.0, 5.1 Hz, 2H), 3.22 (s, 3H), 2.63 (dd, J = 15.4, 8.7 Hz, 1H), 3.57 
(dd, J = 11.0, 5.1 Hz, 1H), 1.42 (s, 3H). 
13C NMR (101 MHz, deuterium oxide) δ 181.71, 171.41, 142.64, 131.71, 128.97, 123.73, 122.69, 109.79, 50.59, 46.90, 
36.35, 26.20, 24.58. 
HRMS (ESI) (m/z) for [M+H]+ (C13H17N2O3) calculated 249.1234, observed 249.1236.  
Enantiopurity (both diastereomers): >99%. 
 
Compound 7 (HCl salt). The product was obtained as a mixture of >98:2 of two diastereomers 
(according to HPLC-MS analysis). The minor diastereomer was not detectable in NMR.  
Major diastereomer (S, S) – (α, γ): 1H NMR (400 MHz, deuterium oxide) δ 7.31 (dd, J = 7.8, 1.7 
Hz, 1H), 7.21 (dt, J = 7.8, 1.6 Hz, 1H), 6.92 (dt, J = 7.6, 1.3 Hz, 1H), 6.86 (dd, J = 8.0, 1.2 Hz, 1H), 
4.46 (dd, J = 11.0, 3.2 Hz, 1H), 2.97 – 2.85 (m, 1H), 2.16 (dd, J = 13.6, 3.2 Hz, 1H), 1.52 (s, 3H). 
13C NMR (101 MHz, deuterium oxide) δ 185.23, 177.11, 153.76, 129.06, 127.70, 120.12, 116.08, 53.21, 46.11, 38.82, 
22.94. 
HRMS (ESI) (m/z) for [M+H]+ (C12H14NO4) calculated 236.0917, observed 236.0913.  
Enantiopurity: >99%. 
 
Compound 8 (HCl salt). The product was obtained as a mixture of >99:1 of two diastereomers 
(according to HPLC-MS analysis). The minor diastereomer was not detectable in NMR.  
Major diastereomer (S, S, S) – (α, γ, δ): 1H NMR (400 MHz, methanol-d4) δ 7.46 – 7.22 (m, 
4H), 3.90 (dd, J = 10.8, 7.2 Hz, 1H), 3.56 (dd, J = 31.6, 17.3 Hz, 2H), 2.84 (dd, J = 13.4, 7.3 Hz, 
1H), 2.42 (dd, J = 13.4, 10.7 Hz, 1H), 1.34 (s, 3H). 13C NMR (101 MHz, methanol-d4) δ 169.12, 144.95, 135.72, 128.54, 
128.54, 125.12, 122.96, 109.26, 58.14, 57.29, 39.59, 37.23, 20.54. 
HRMS* (ESI) (m/z) for [M+H-H2O] + (C12H12NO3) calculated 216.1019, observed 216.1025.  
Enantiopurity: >99%. 
*Protonation of the hydroxyl group at Cδ leads to the formation of the imine via water elimination. 
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Compound 12 (HCl salt). The product was obtained as a 5:4 mixture of two diastereomers, 
which could be separated using a C-18 silica column on a Biotage Isolera One purification 
system (see 8.5). 
Major diastereomer (S, S) – (α, γ): 1H NMR (400 MHz, deuterium oxide) δ 7.49 (d, J = 7.8 Hz, 
1H), 7.41 (d, J =8.1 Hz, 1H), 7.20 (d, J = 10.8 Hz, 1H), 7.04 (d, J = 7.5 Hz, 1H), 4.47 (dd, J = 9.1, 
3.8 Hz, 1H), 2.59 (dd, J = 15.5, 3.8 Hz, 1H), 2.36 (dd, J = 15.5, 9.1 Hz, 1H). 13C NMR (101 MHz, 
deuterium oxide) δ 180.62, 171.54, 140.22, 130.65, 129.61, 123.90, 123.67, 111.40, 74.90, 49.48, 35.97. 
Minor diastereomer (S, R) – (α, γ): 1H NMR (400 MHz, deuterium oxide) δ 7.45 (d, J = 7.6 Hz, 1H), 7.38 (t, J = 7.7 Hz, 
1H), 7.18 (t, J = 7.7 Hz, 1H), 7.03 (d, J = 7.8, 0.8 Hz, 1H), 4.64 (dd, J = 9.6, 3.7 Hz, 1H), 2.59 (dd, J = 15.6, 9.4 Hz, 1H), 
2.43 (dd, J = 15.8, 3.7 Hz, 1H). 13C NMR (101 MHz, deuterium oxide) δ 180.09, 171.58, 139.88, 130.77, 130.24, 123.72, 
123.60, 111.12, 74.45, 49.15, 36.21. 
HRMS (ESI) (m/z) for [M+H] + (C11H13N2O4) calculated 237.087, observed 237.0866.  
Enantiopurity >99%. Due to signal overlap after derivatization and LCMS separation (see 8.7), an ee>99% could only 
be confirmed for one diastereomer. 
 
For the following two products, detailed analytics (NMR, HRMS and optical purity) could not be accomplished as the 
overall yield was not sufficient to obtain >1 mg of isolated product.  
 
Compound 10: LC-MS chromatogram for expected mass [M+H]+=263 
 
 
 
 
Compound 11: LC-MS chromatogram for expected mass [M+H]+=277 
 
  
 
11 DNA and Protein sequences 
 
Parent Protein Pf0A9 E104G2 
 
Nucleotide sequence: 
ATGTGGTTCGGTGAATTTGGTGGTCAGTACGTGCCAGAAACGCTGGTTGGACCCCTGAAAGAGCTGGAAAAAGCTTACAAACG
TTTCAAAGATGACGAAGAATTCAATCGTCAGCTGAATTACTACCTGAAAACCTGGGCAGGTCGTCCAACCCCACTGTACTACGC
AAAACGCCTGACTGAAAAAATCGGTGGTGCTAAAGTCTACCTGAAACGTGAAGACCTGGTTCACGGTGGTGCACACAAGACCA
ACAACGCCATCGGTCAGGCACTGCTGGCAAAGCTCATGGGTAAAACTCGTCTGATCGCTGGGACCGGTGCTGGTCAGCACGGC
GTAGCGACTGCAATGGCTGGTGCACTGCTGGGCATGAAAGTGGACATTTACATGGGTGCTGAGGACGTAGAACGTCAGAAAC
TGAACGTATTCCGTATGAAGCTGCTGGGTGCAAACGTAATTCCAGTTAACTCCGGTTCTCGCACCCTGAAAGACGCATTTGACG
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AGGCTCTGCGTGATTGGGTGGCTACTTTTGAATACACCCACTACCTAATCGGTTCCGTGGTCGGTCCACATCCGTATCCGACCAT
CGTTCGTGATTTTCAGTCTGTTATCGGTCGTGAGGCTAAAGCGCAGATCCTGGAGGCTGAGGGTCAGCTGCCAGATGTAATCG
TTGCTTGTGTTGGTGGTGGCTCTAACGCGATGGGTATCTTTTACCCGTTCGTGAACGACAAAAAAGTTAAGCTGGTTGGCGTTG
AGGCTGGTGGTAAAGGCCTGGAATCTGGTAAGCATTCCGCTAGCCTGAACGCAGGTCAGGTTGGTGTGTCCCATGGCATGCTG
TCCTACTTTCTGCAGGACGAAGAAGGTCAGATCAAACCAAGCCACTCCATCGCACCAGGTCTGGATCATCCAGGTGTTGGTCCA
GAACACGCTTACCTGAAAAAAATTCAGCGTGCTGAATACGTGGCTGTAACCGATGAAGAAGCACTGAAAGCGTTCCATGAACT
GAGCCGTACCGAAGGTATCATCCCAGCTCTGGAATCTGCGCATGCTGTGGCTTACGCTATGAAACTGGCTAAGGAAATGTCTCG
TGATGAGATCATCATCGTAAACCTGTCTGGTCGTGGTGACAAAGACCTGGATATTGTCCTGAAAGCGTCTGGCAACGTGCTCGA
GCACCACCACCACCACCACTGAG 
 
Protein sequence: 
MWFGEFGGQYVPETLVGPLKELEKAYKRFKDDEEFNRQLNYYLKTWAGRPTPLYYAKRLTEKIGGAKVYLKREDLVHGGAHKTNNAI
GQALLAKLMGKTRLIAGTGAGQHGVATAMAGALLGMKVDIYMGAEDVERQKLNVFRMKLLGANVIPVNSGSRTLKDAFDEALRD
WVATFEYTHYLIGSVVGPHPYPTIVRDFQSVIGREAKAQILEAEGQLPDVIVACVGGGSNAMGIFYPFVNDKKVKLVGVEAGGKGLES
GKHSASLNAGQVGVSHGMLSYFLQDEEGQIKPSHSIAPGLDHPGVGPEHAYLKKIQRAEYVAVTDEEALKAFHELSRTEGIIPALESAH
AVAYAMKLAKEMSRDEIIIVNLSGRGDKDLDIVLKASGNVLEHHHHHH 
 
Final variant Pfquat 
 
Nucleotide sequence: 
ATGTGGTTCGGTGAATTTGGTGGTCAGTACGTGCCAGAAACGCTGGTTGGACCCCTGAAAGAGCTGGAAAAAGCTTACAAACG
TTTCAAAGACGACGAAGAATTCAATCGTCAGCTGAATTACTACCTGAAAACCTGGGCAGGTCGTCCAACTCCACTGTACTACGC
AAAACGCCTGACTGAAAAAATCGGTGGTGCTAAAGTCTACCTGAAACGTGAAGACCTGGTTCACGGTGGTGCACACAAGACCA
ATAACGCCATCGGTCAGGCACTGCTGGCAAAGCTCATGGGTAAAACTCGTCTGATCGCTGGGACCGGTGCTGGTCAGCACGGC
GTAGCGACTGCAATGGCTGGTGCACTGCTGGGCATGAAAGTGGACATTTACATGGGTGCTGAGGACGTAGAACGTCAGAAAC
TGAACGTATACCGTATGAAGCTGCTGGGTGCAAACGTAATTCCAGTTAACTCCGGTTCTCGCACCGTGAAAGACGCATTTGACG
AGGCTCTGTGTGATCGGGTGGCTACTTTTGAATACACCCACTACCTAATCGGTACCGTGTGGGGTCCACATCCGTATCCGACCA
TCGTTCGTGATTTTCAGACTGTTATCGGTCGTGAGGCTAAAGCGCAGATCCTGGAGGCTGAAGGTCGGCTGCCAGATGCAATC
GTTGCTTGTGTTGGTGGTGGCTCTAACGCGATGGGTATCTTTTACCCGTTCGTGAACGACAAAAAAGTTAAGCTGGTTGGCGTT
GAGGCTGGTGGTAAAGGCCTGGAATCTGGTAAGCATTCCGCTAGCCTGAACGCAGGTCAGGTTGGTGTGTCCCATGGCATGCT
GTCCTACTTTCTGCAGGACGAAGAAGGTCAGATCAAACCAAGCCACTCCATCGCACCAGGTCTGGATCATCCAGGTGTTGGTCC
AGAACACGCTTACCTGAAAAAAATTCAGCGTGCTGAATACGTGGCTGTAACCGATGAAGAAGCACTGAAAGCGTTCCATGAAC
TGAGCCGTACCGAAGGTATCATCCCAGCTCTTGAATCTGCGCATGCTGTGGCTTACGCTATGAAACTGGCTAAGGAAATGTCTC
GTGATGAGATCATCATCGTAAACCTGTCTGGTCGTGGTGACAAAGACCTGGATATTGTCCTGAAAGCGTCTGGCAACGTGCTC
GAGCACCACCACCACCACCACTGA 
 
Protein sequence (The 9 beneficial mutations are highlighted in red):  
MWFGEFGGQYVPETLVGPLKELEKAYKRFKDDEEFNRQLNYYLKTWAGRPTPLYYAKRLTEKIGGAKVYLKREDLVHGGAHKTNNAI
GQALLAKLMGKTRLIAGTGAGQHGVATAMAGALLGMKVDIYMGAEDVERQKLNVYRMKLLGANVIPVNSGSRTVKDAFDEALCD
RVATFEYTHYLIGTVWGPHPYPTIVRDFQTVIGREAKAQILEAEGRLPDAIVACVGGGSNAMGIFYPFVNDKKVKLVGVEAGGKGLES
GKHSASLNAGQVGVSHGMLSYFLQDEEGQIKPSHSIAPGLDHPGVGPEHAYLKKIQRAEYVAVTDEEALKAFHELSRTEGIIPALESAH
AVAYAMKLAKEMSRDEIIIVNLSGRGDKDLDIVLKASGNVLEHHHHHH 
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